These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2939251)

  • 1. The anterior commissure in Down's syndrome.
    Sylvester PE
    J Ment Defic Res; 1986 Mar; 30 ( Pt 1)():19-26. PubMed ID: 2939251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome.
    Teipel SJ; Schapiro MB; Alexander GE; Krasuski JS; Horwitz B; Hoehne C; Möller HJ; Rapoport SI; Hampel H
    Am J Psychiatry; 2003 Oct; 160(10):1870-8. PubMed ID: 14514503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The perforant pathway in Down's syndrome.
    Mann DM; Yates PO
    Ann Neurol; 1987 Jun; 21(6):613-4. PubMed ID: 2955740
    [No Abstract]   [Full Text] [Related]  

  • 4. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
    Teipel SJ; Alexander GE; Schapiro MB; Möller HJ; Rapoport SI; Hampel H
    Brain; 2004 Apr; 127(Pt 4):811-24. PubMed ID: 14985261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
    Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease.
    de la Monte SM; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1990 Sep; 49(5):509-20. PubMed ID: 2148772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of neurones from cortical and subcortical areas in Down's syndrome patients at middle age. Quantitative comparisons with younger Down's patients and patients with Alzheimer's disease.
    Mann DM; Yates PO; Marcyniuk B; Ravindra CR
    J Neurol Sci; 1987 Aug; 80(1):79-89. PubMed ID: 2956368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The topography of plaques and tangles in Down's syndrome patients of different ages.
    Mann DM; Yates PO; Marcyniuk B; Ravindra CR
    Neuropathol Appl Neurobiol; 1986; 12(5):447-57. PubMed ID: 2946973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of the nucleus basalis in Down's syndrome.
    Casanova MF; Walker LC; Whitehouse PJ; Price DL
    Ann Neurol; 1985 Sep; 18(3):310-3. PubMed ID: 2932050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The limbic system in Alzheimer's disease. A neuropathologic investigation.
    Hopper MW; Vogel FS
    Am J Pathol; 1976 Oct; 85(1):1-20. PubMed ID: 135514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down's syndrome and Alzheimer's disease: a review.
    Oliver C; Holland AJ
    Psychol Med; 1986 May; 16(2):307-22. PubMed ID: 2941815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cerebral degeneration in Down's syndrome].
    Hirabayashi K; Ikeda K; Shimokawa K; Orthner H
    Folia Psychiatr Neurol Jpn; 1979; 33(1):81-96. PubMed ID: 156670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathological structure of blood vessels of cerebral cortex in Alzheimer's disease in comparison with various other types of mental retardation (oligophrenia, Down's syndrome)].
    Orlova ML
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(10):38-41. PubMed ID: 1705071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease and Down's syndrome.
    Mann DM
    Histopathology; 1988 Aug; 13(2):125-37. PubMed ID: 2971602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Lewy bodies in Trisomy 21 (Down's syndrome).
    Raghavan R; Khin-Nu C; Brown A; Irving D; Ince PG; Day K; Tyrer SP; Perry RH
    Can J Neurol Sci; 1993 Feb; 20(1):48-51. PubMed ID: 8467429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype.
    Hyman BT; West HL; Rebeck GW; Lai F; Mann DM
    Arch Neurol; 1995 Apr; 52(4):373-8. PubMed ID: 7710373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin immunoreactivity in post-mortem brain is increased in Down's syndrome but not in Alzheimer-type dementia.
    Yates CM; Fink G; Bennie JG; Gordon A; Simpson J; Eskay RL
    J Neurol Sci; 1985 Mar; 67(3):327-35. PubMed ID: 3157784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia.
    Aylward EH; Li Q; Honeycutt NA; Warren AC; Pulsifer MB; Barta PE; Chan MD; Smith PD; Jerram M; Pearlson GD
    Am J Psychiatry; 1999 Apr; 156(4):564-8. PubMed ID: 10200735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reductions in soluble brain proteins in older subjects with Down's syndrome.
    Borthwick NM; Gordon A; Yates CM
    J Neurol Sci; 1985 May; 68(2-3):205-14. PubMed ID: 3159852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.
    Godridge H; Reynolds GP; Czudek C; Calcutt NA; Benton M
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):775-8. PubMed ID: 2440994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.